Comparison of 60 and 80 mg/m2of daunorubicin in induction therapy of acute myeloid leukaemia

Author:

Vaezi Mohammad1,Bahar Babak1,Mousavi Asadollah1,Yaghmai Marjan1,Kasaeian Amir12,Souri Maryam1,Jahani Mohammad1,Alimoghaddam Kamran1,Ghavamzadeh Ardeshir1

Affiliation:

1. Hematology-Oncology and Stem Cell Transplantation Research Center; Tehran University of Medical Sciences; Tehran Iran

2. Department of Epidemiology and Biostatistics, School of Public Health; Tehran University of Medical Sciences; Tehran Iran

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference16 articles.

1. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B;Rai;Blood,1981

2. A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia;The AML Collaborative Group;Br J Haematol,1998

3. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest oncology group study;Weick;Blood,1996

4. A prospective evaluation of the roles of allogeneic marrow transplantation and low-dose monthly maintenance chemotherapy in the treatment of adult acute myelogenous leukemia (AML): a southwest oncology group study;Hewlett;Leukemia,1995

5. Anthracycline dose intensification in acute myeloid leukemia;Fernandez;N Engl J Med,2009

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3